Unknown OBSERVATIONAL NCT05080023

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

Sponsor: Chi-Ming Chu

Conditions Cardiac Force Index Cardiac Output Enhanced External Counterpulsation (EECP)

Interventions Enhanced External Counterpulsation (EECP)

Updated 6 times since 2021 Last updated: Feb 22, 2022 Started: Feb 22, 2022 Primary completion: Dec 31, 2022 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiac Force Index and Cardiac Output and is currently ongoing. Chi-Ming Chu leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Mar 2022 — Mar 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2021 — Mar 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chi-Ming Chu
Dr. Chiang, Shang-lin
Dr. Liang-Cheng Chen

Data source: National Defense Medical Center, Taiwan

For direct contact, visit the study record on ClinicalTrials.gov .

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials